We are pleased to announce the launch of the latest edition of the Sequencing Buyer’s Guide, an intelligence-led report that is unique compared to others on the market.
It is carefully curated with the guidance and insights of our expert contributors, who provide knowledge that can’t be found anywhere else, AI-derived or otherwise. This is complemented by information on commercially available platforms and machines, and those that are yet to come to market. Our contributors have provided support on the capabilities and considerations for different technologies through their own experiences, and discussions on how the commercial sequencing landscape may yet develop, helping you to make informed purchasing decisions.
Highlights from this edition include:
- Interviews and discussions with experts working across the sequencing landscape, who share their insights on how the field is developing and what to consider when choosing a new platform in this innovative and competitive climate
- Up to date specifications and releases from the major sequencing companies, alongside the latest information about novel platforms not yet commercially available, such as Roche’s SBX and Illumina’s Constellation technology
- A focus on how the role of genomics is changing as we move into the multimodal era: from sequencers that can perform multiomics assays to the benefits of combining phenomic data with large population studies
- Helpful information for scaling up or outsourcing workflows; explore a range of automation solutions and sequencing services to suit a variety of platforms and throughput needs
Thank you to our contributors for sharing their time and expertise:
- Miten Jain, Assistant Professor, Northeastern University
- Heidi Rehm, Co-Director, Medical and Population Genetics, Broad Institute
- Michael Quail, Principal Scientific Manager Sequencing R&D, Wellcome Sanger Institute
- Sneha Goenka, Assistant Professor, Princeton University
- Catharine Aquino, Unit Head (Genomics), Functional Genomics Center Zurich (ETH Zürich)
- Mark Kristiansen, Director, UCL Genomics
- Fritz Sedlazeck, Associate Professor, Baylor College of Medicine
- Samira Asgari, Assistant Professor, Icahn School of Medicine at Mount Sinai
- Matt Loose, Professor of Computational Biology and Developmental Genetics, University of Nottingham
- Sally James, Head of Genomics, University of York
- Adam Cribbs, Associate Professor, Botnar Research Centre, University of Oxford
- Dominic Horner, Single Cell and Spatial Transcriptomics Applications Specialist, UCL Genomics
- Alice Garrett, Clinical Fellow, Institute of Cancer Research; Department of Clinical Genetics, St George’s Hospital
- Nurul Sarifah, Applications Specialist (Microarrays) and Proteomics Lead, UCL Genomics
- Shawn Baker, Genomics Startup Advisor/Business Consultancy, SanDiegOmics
- Saba Asam, Single Cell and Spatial Transcriptomics Lead, UCL Genomics
- Ojasvi Chaudhury, Senior Scientist, AstraZeneca
- Kerra Pearce, Facility Coordinator and Sustainability Lead, UCL Genomics
- Andrea Maurizio Cabibbe, Research Associate, IRCCS San Raffaele Scientific Institute
- Sian Goldsworthy, Bioinformatician, UCL Genomics
To download this latest edition and explore the commercial sequencing landscape, click the button below.
